Vertex Pharmaceuticals | VRTX - Interest Income



Vertex Pharmaceuticals reported $122.4M in Interest Income for its fiscal quarter ending in June of 2025.


Interest Income Change Date
AbbVie USD 73M 19M Mar/2025
Acadia Pharmaceuticals USD 7.24M 658K Jun/2025
Agios Pharmaceuticals USD 14.51M 1.57M Jun/2025
Alnylam Pharmaceuticals USD 27.49M 1.19M Jun/2025
Arrowhead Research USD 9.62M 2.01M Mar/2025
Biogen USD 32.3M 8.4M Jun/2025
BioMarin Pharmaceutical USD 18.83M 186K Jun/2025
Gilead Sciences 73M 21M Jun/2025
Incyte 25.14M 2.21M Jun/2025
Insmed 0 0 Mar/2025
Ionis Pharmaceuticals -0.66 0.29 Dec/2024
J&J 332M 51M Mar/2025
Merck USD 109M 37M Mar/2025
Moderna USD 81M 9M Jun/2025
Pfizer USD 156M 13M Jun/2025
Regeneron Pharmaceuticals 174.8M 1.3M Jun/2025
Roche Holding 2M 12M Dec/2020
Sanofi 76M 10M Jun/2025
Sarepta Therapeutics USD 7.14M 3.05M Jun/2025
Ultragenyx Pharmaceutical USD 5.79M 1.04M Jun/2025
United Therapeutics USD 51.3M 200K Jun/2025
Vertex Pharmaceuticals USD 122.4M 1.5M Jun/2025